Oct 9, 2012 by Max MacalusoWhy Did Shares of Affymax Jump Today?So long, 52-week high -- it was nice knowing you.
Oct 8, 2012 by Max MacalusoToday's Top Health-Care MoversA look back at the day's news in the sector.
Oct 6, 2012 by Max Macaluso1 Number All Biotech Investors Need to WatchWatching the burn rate can help you avoid watching your investments go up in smoke.
Oct 1, 2012 by Max MacalusoStrong Results From This Roche, ImmunoGen PartnershipThe companies reported positive clinical study results for its development cancer drug T-DM1 today.
Aug 30, 2012 by Max MacalusoWill 1 Patent Destroy This Dow Dividend Stock?Merck’s leading drug just lost its U.S. patent protection. What does this mean for the future of this pharmaceutical stock?
Aug 23, 2012 by Max MacalusoHas Jazz Pharmaceuticals Played Its Last Note?Jazz Pharmaceuticals has been a great long-term investment since it went public -- but will generic competitors ruin its business?
